Table 2.

Genotype and allele distribution of TIM-3 and LGALS9 SNPs among female patients and female controls.

			Cases		Controls
SNP	Genotype	Allele	N	%	N	%	OR	95% CI		p-Value
rs1036199
	AA		58	67.44	91	61.49	1			0.191
	AC		28	32.56	52	35.14	0.849	0.484	1.489
	CC		0	0.00	5	3.38	0.142	0.008	2.620
	AC + CC		28	32.56	57	38.51	0.775	0.445	1.352	0.362
	AA + AC		86	100.00	143	96.62	-	-	-	-
		A	144	83.72	234	79.05	1
		C	28	16.28	62	20.95	0.740	0.454	1.207	0.217
rs10057302
	CC		83	96.51	134	90.54	1			-
	AC		3	3.49	14	9.46	0.389	0.117	1.289
	AA		0	0.00	0	0.00	-	-	-
	AC + AA		3	3.49	14	9.46	0.389	0.117	1.289	0.090
	CC + AC		86	100.00	148	100.00	-	-	-	-
		C	169	98.26	282	95.27	1
		A	3	1.74	14	4.73	0.402	0.123	1.313	0.096
rs3751093
	GG		41	48.24	90	60.81	1			0.137
	AG		34	40.00	48	32.43	1.551	0.877	2.745
	AA		10	11.76	10	6.76	2.181	0.860	5.533
	AG + AA		44	51.76	58	39.19	1.659	0.971	2.834	0.063
	GG + AG		75	88.24	138	93.24	0.545	0.222	1.341	0.190
		G	116	68.24	228	77.03	1
		A	54	31.76	68	22.97	1.561	1.025	2.375	0.038
rs361497
	GG		39	45.88	85	57.43	1			0.132
	AG		35	41.18	53	35.81	1.436	0.814	2.534
	AA		11	12.94	10	6.76	2.371	0.947	5.935
	AG + AA		46	54.12	63	42.57	1.585	0.929	2.704	0.090
	GG + AG		74	87.06	138	93.24	0.491	0.203	1.187	0.113
		G	113	66.47	223	75.34	1
		A	57	33.53	73	24.66	1.541	1.020	2.327	0.040
rs4239242
	TT		30	35.29	60	40.54	1			0.309
	CT		35	41.18	65	43.92	1.075	0.592	1.953
	CC		20	23.53	23	15.54	1.730	0.830	3.609
	CT + CC		55	64.71	88	59.46	1.244	0.718	2.155	0.429
	TT + CT		65	76.47	125	84.46	0.598	0.308	1.162	0.131
		T	95	55.88	185	62.50	1
		C	75	44.12	111	37.50	1.315	0.897	1.928	0.161
rs4794976
	TT		36	42.35	83	56.08	1			0.060
	GT		31	36.47	48	32.43	1.486	0.821	2.690
	GG		18	21.18	17	11.49	2.418	1.130	5.174
	GT + GG		49	57.65	65	43.92	1.729	1.011	2.955	0.044
	TT + GT		67	78.82	131	88.51	0.486	0.237	0.994	0.047
		T	103	60.59	214	72.30	1
		G	67	39.41	82	27.70	1.696	1.139	2.525	0.009